From China to the Global Stage: Hengrui Showcases Innovative Research at ESMO Congress 2026, Exploring New Approaches to Oncology Treatment

Record 64 Research Presentations Highlight Hengrui's Oncology R&D Strength and Growing International Reach

MADRID and SHANGHAI, Oct. 27, 2026 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2026 recently concluded in Madrid. As a leading innovator in China's pharmaceutical industry, Hengrui Pharma presented 64 research findings at this year's congress, marking a new record for the company and showcasing the strength and clinical potential of Chinese pharmaceutical innovation on the international stage.

Broad Oncology Research Portfolio Showcases Chinese Innovation on the Global Stage

Hengrui has long been committed to advancing cancer treatment, and its research achievements received further recognition at this year's ESMO Congress. A total of 64 oncology research studies were accepted for presentation, including three Proffered Papers, three Rapid Oral presentations, 32 Posters and 26 e-Posters. The research covered more than ten cancer areas, including gastrointestinal, lung and breast cancers, gynecological and genitourinary cancers, and other tumor types, as well as supportive care. It involved 21 innovative drugs in China, including nine approved products and 12 investigational candidates. [1]

Hengrui Oncology has participated in the ESMO Congress for 11 consecutive years, beginning in 2016. Since 2023, the company has presented nearly 200 research findings at the congress, demonstrating its strength in oncology innovation and highlighting its role in bringing Chinese pharmaceutical innovation to the international stage.

Dr Karen Atkin, Head of Global Business and Portfolio Strategy at Hengrui Pharma, said: "ESMO is an important platform for scientific exchange in oncology worldwide. We are delighted to share Hengrui's latest research and engage with peers worldwide on emerging scientific advances and potential areas of collaboration. Looking ahead, we will continue to advance our international development strategy and expand opportunities to develop our innovative medicines in partnership with international collaborators, with the aim of bringing more treatment options to patients worldwide."

From Participation to Real Impact: Advancing Cancer Treatment Through High-Value Innovation

Hengrui Oncology's progress is underpinned by sustained investment in R&D. With decades of experience in oncology drug discovery and development, Hengrui Pharma has established an integrated four-part approach to innovative therapies, encompassing precision therapy, immunotherapy, targeted therapy and supportive care. Alongside further developing established technology platforms such as antibody-drug conjugates (ADCs), Hengrui Oncology is also exploring emerging technologies, including artificial intelligence-driven drug discovery (AIDD), to integrate AI into the drug development process and improve R&D efficiency.

As of June 2026, 14 independently developed Class 1 innovative oncology medicines had been approved for marketing in China. Hengrui Oncology has established a comprehensive portfolio spanning seven major disease areas, oncology supportive care, and areas of substantial unmet medical need. It also has around 50 innovative assets in clinical development, with around 100 clinical studies underway worldwide. Several products have received U.S. FDA Orphan Drug and Fast Track designations.

As a key driver of Hengrui's innovation-led transformation, oncology is one of the company's most research-intensive business areas and among those with the most established pathways for translating innovation into commercial products. In 2025, sales of innovative oncology medicines accounted for 81.02% of Hengrui's total innovative medicine sales revenue,[2] reflecting the company's continued efforts to translate innovation into both clinical and commercial value.

Building on its established commercial foundation, Hengrui Oncology is actively expanding its presence in the global innovation landscape. Through its network of 15 R&D sites across Asia, Europe, North America, Australia and other key markets, the company is advancing international multicenter clinical trials for multiple innovative programs and developing R&D and regulatory capabilities in major global markets. Hengrui Pharma is also steadily pursuing a range of collaboration models, including out-licensing, co-development, and NewCo partnerships, to support international collaboration on oncology innovation projects and accelerate the expansion of innovative therapies into overseas markets.

A patient-focused philosophy remains central to Hengrui Oncology's R&D. Looking ahead, Hengrui Oncology will continue to drive innovation at its source and bring more Chinese-developed medicines to international markets, expanding treatment options for cancer patients worldwide and contributing Chinese innovation and expertise to the global fight against cancer.

References:

- ESMO Congress Official Website: https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal/session

- Hengrui's 2025 Annual Report: http://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2026-03-26/600276_20260326_RAEC.pdf

About Hengrui Pharma

Hengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. Its therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Driven by a patient-focused philosophy since its founding in 1970, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology. For more information, visit us at Hengrui.com and follow us on LinkedIn.

About Hengrui Oncology

Hengrui Oncology is one of Hengrui Pharma's core strategic business areas. Following decades of development, it has established a comprehensive portfolio spanning seven major disease areas, including gastrointestinal and breast cancers, as well as oncology supportive care. As of June 2026, 14 independently developed Class 1 innovative medicines, including AiRuiKa® (Camrelizumab for Injection), HengQu® (Herombopag Olamine Tablets) and AiWeiDa® (Trastuzumab Rezetecan for Injection), had been launched in China. Supported by its global R&D system and a range of international collaborations, Hengrui Oncology is accelerating its transition from innovation in China to innovation for the world, offering more precise, accessible and high-quality treatment options for patients with cancer.

For more information, please visit: www.hengrui.com

SOURCE Hengrui Pharma

Share this article

Envision Energy Unveils AI-powered New Energy System for Mining and Smelting Industry at All Energy Australia

The system combines renewable energy, storage and integrated dispatch system to deliver reliable, affordable power and support industrial decarbonisation.

MELBOURNE, Australia, Oct. 28, 2026 /PRNewswire/ -- Envision Energy, a global leader in green technology, unveiled its AI-powered new energy system for the mining and smelting industry at All Energy Australia, combining wind, solar, battery storage, gas turbines fueled by green hydrogen or green ammonia as well as integrated dispatch and control system to help lower energy costs, ensure reliable power supply and accelerate decarbonisation.

The system addresses a central challenge across the mining and smelting sector: How to build up a hybrid new energy system to deliver affordable but reliable green power supply to the mining remote sites with weak or even no grid connections?

Envision's approach coordinates renewable generation, battery storage and backup power within an integrated energy system. Its weather and energy AI foundation models, together with the EnOS AI platform, support renewable generation forecasting and load forecasting, system planning and real-time dispatch. These capabilities optimize the coordination of generation, storage and industrial loads as weather and operating conditions change, helping maintain reliable supply while lowering overall energy costs.

Safety and reliability are critical to the system's design, supporting mining and smelting operations across grid-connected, weak-grid and off-grid environments. The wind-storage integrated turbines smooth wind power output, while grid-forming battery storage supports system stability. A seven-layer protection and control framework coordinates dispatch, stability control, protection and recovery, helping the system manage sudden load changes, sustain off-grid operation and restore supply following an outage.

To further reduce emissions from backup generation, Envision is also exploring the use of gas turbines fueled by green hydrogen or green ammonia as alternatives to diesel generators. Envision's energy and carbon management capabilities support product carbon-footprint accounting and provide data for green certification processes, helping producers meet customer demand for lower-carbon minerals and metals and demonstrate ESG performance in support of green financing.

Envision's offering spans planning, engineering, delivery and ongoing operations, alongside financing options. Through site-specific system optimisation, the system targets around 20% lower overall energy costs, a renewable electricity share above 80% and power supply reliability exceeding 99.95%, depending on local resources, system configuration and production requirements.

Envision is deploying its energy solutions across the mining and smelting sector, tailoring them to local energy resources and operational requirements. In Western Australia's Pilbara region, Envision is supplying wind turbines for Fortescue's Nullagine Wind Project, contributing to the renewable energy infrastructure supporting the miner's Real Zero strategy.

In Baotou, China, Envision has integrated wind power, battery storage, and loads into an integrated energy system for green alloy production. The project meets more than 70% of its electricity needs with renewable energy and cuts annual carbon dioxide emissions by over 200,000 tonnes, demonstrating how renewables can power energy-intensive alloy production.

At All Energy Australia, Envision is engaging with mining and smelting producers and project partners to develop AI-powered new energy systems tailored to local resources, industrial loads and decarbonisation goals.

Share this article

NFL Week 8

We’ll skip the early start across the pond this week, as we have a traditional Sunday schedule that gets going at 1 p.m. ET. We don’t have a lot of bangers on paper, but Browns vs. Steelers brings two 5-2 teams together in Pittsburgh. Ravens vs. Bills and Vikings vs. Lions could have fireworks in the early window, while Chiefs vs. Broncos headlines the late window. The Eagles minus Jalen Hurts draw yet another primetime spot against the Commanders on SNF, while Bears vs. Seahawks is our Monday Nighter.

This is an awesome week to become a VSiN Pro subscriber with the Sports Equinox offer, VSiN Pro access from now through May 1 for $120.

Bookmark this page because this will serve as our “Hub” for all of our Week 8 NFL content. We will do one of these every week with a bunch of links to our original content, betting tools, and more.

We have a new tool here at VSiN, as the OptaAI Player Prop Projections are now available. Be sure to consult these before locking in your Week 8 Player Props.

Also, join the Edge Boost/VSiN Average Joe Football Contest to take your shot at winning some prizes!

Download the VSiN Watch App to watch or listen to VSiN from anywhere!

Become a VSiN Pro Subscriber to get unfiltered access to everything we do, plus you can watch a livestream of our broadcast channel!

For help with your NFL Pick ‘Em Pools or NFL Survivor, check out the tools available at PoolGenius by clicking the links.

Week 8 NFL Schedule & Matchups

Week 8 NFL Betting Splits: DraftKings | Circa

NFL Week 8 Picks Articles

Coming soon.

NFL Week 8 Articles

Additional NFL Betting Tools:

Steve Makinen’s NFL Power Ratings

An explanation of Steve Makinen’s NFL Power Ratings

Steve Makinen’s Betting Splits Systems for 2026

Steve Makinen’s 30 Top NFL Team Betting Trends for 2026

VSiN Livestream ($)

Sony Semiconductor Solutions to Release Approx. 50-Effective Megapixel CMOS Image Sensor for Mobile Applications With Superb Low-Light Performance and 4K HDR Video Recording

Delivering top-tier technology honed in the LYTIA high-end series

ATSUGI, Japan, Oct. 28, 2026 /PRNewswire/ -- Sony Semiconductor Solutions Corporation (Sony) today announced the upcoming release of the LYTIA 720, an approximately 50-effective megapixel*1 image sensor for mobile applications that delivers industry-leading*2 low-light performance and supports 4K 60 fps HDR video recording.

Designed for use on the main camera of mobile devices, the new sensor inherits technologies developed for Sony's LYTIA high-end series. Sony's proprietary low-noise circuit technology reduces random noise in dark environments by approximately 50% compared to a conventional product*3 while achieving a dynamic range of 100 dB through HDR compositing technology. This contributes to high-quality still images and videos in dark environments, high-contrast scenes, and a wide range of other shooting conditions. By optimizing AD conversion circuits, the new sensor supports 4K 60 fps video recording with all-pixel autofocus while HDR is enabled.

The new sensor offers high imaging performance in a 1/1.56-type size, which is being widely adopted in the smartphone market. Sony aims to deliver high-quality imaging experiences to more users.

Main Features

Proprietary UHCG circuit technology delivers industry-leading*2 low-light performance

Optimized AD conversion circuits enable 4K 60 fps HDR video recording with all-pixel autofocus

Video: CMOS Image Sensor for Mobile: LYTIA 720 | 4K 60fps DCG-HDR On/Off Comparison Video | Sony Official

Hybrid Frame-HDR technology delivers a 100 dB dynamic range

For more information on LYTIA, Sony's mobile image sensor brand, please visit the LYTIA brand site:

https://www.sony-semicon.com/en/products/is/mobile/index.html

* LYTIA and the LYTIA logo are registered trademarks or trademarks of Sony Group Corporation.

* All product and service names that appear in this press release are the trademarks or registered trademarks of their respective owners.

Share this article

Xylem's third-quarter revenue came in roughly $80 million below Wall Street's estimate, and adjusted EPS fell short of consensus. An investigation into potential securities law violations is reviewing losses suffered by XYL shareholders.

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- About $80 million in expected revenue was missing when Xylem Inc. (NYSE: XYL) reported third-quarter results on October 27, 2026, and the stock fell as the market reacted to the miss. If you bought XYL shares and are now holding losses, act today. Shareholders who lost money are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

Wall Street expected third-quarter revenue of approximately $2.28 billion. Xylem reported approximately $2.20 billion, a shortfall of about 3.5%. The results were shy of the company's projections as well. Xylem cut full-year revenue projections from "roughly 9.2 billion" to "approximately $8.95 billion." Adjusted earnings per share came in at $1.44, below consensus estimates of about $1.45.

Xylem attributed the quarter's results to project delays and cautious customer spending. The October 27 report missed on both the top line and the bottom line. Levi & Korsinsky is investigating whether XYL shareholders may have been harmed by potential securities law violations.

If you purchased Xylem stock and suffered a loss, request a free review of your XYL losses or call (212) 363-7500.

ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the XYL Investigation

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Xylem Inc. made materially false or misleading statements regarding its business, operations, and customer demand environment. When the Company disclosed third-quarter revenue of approximately $2.20 billion against analyst estimates of approximately $2.28 billion, the stock price declined.

Q: When did Xylem allegedly mislead investors?A: The investigation concerns statements made before the corrective disclosure that allegedly caused investors to purchase securities at inflated prices.

Q: What is the XYL securities fraud investigation about?A: A securities investigation is pending concerning Xylem Inc. (NYSE: XYL) regarding potentially materially false or misleading statements. Shares fell after the Company disclosed third-quarter revenue of approximately $2.20 billion versus estimates of approximately $2.28 billion, along with adjusted EPS of $1.44 versus consensus of about $1.45.

Q: What do XYL investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my XYL shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought XYL and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE Levi & Korsinsky, LLP

Share this article

SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Anavex Life Sciences Corp. (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (the "Class Period"). Anavex describes itself as "a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsychiatric disorders."

The complaint alleges that Anavex Life Sciences Corp. misled investors regarding its lack of adequate internal controls.

Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should contact Robbins LLP for information before the November 30, 2026, lead plaintiff deadline.

Why Was Anavex Sued?

According to the complaint, during the Class Period, defendants failed to disclose that:

(1) Anavex lacked adequate internal controls;

(2) Anavex understated its potential regulatory challenges as a result of misconduct by former CEO Christopher Missling; and

(3) as a result, defendants' statements about Anavex's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Why Did Anavex Stock Drop?

Plaintiff alleges that on May 6, 2026, Anavex filed a current report on Form 8-K with the Securities and Exchange Commission ("SEC"), that stated that on April 30, 2026, a special committee composed of independent directors of the Board of Directors terminated the employment of the Company's Chief Executive Officer, Christopher Missling, PhD, for, among other things, conduct that was inconsistent with Company policy. On this news, the price of Anavex stock declined by 0.59% on May 6, 2026.

On May 11, 2026, the Company filed with the SEC a notification of late filing on Form 12b-25 indicating that it was unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 by the prescribed May 11, 2026 due date. On this news, the Company's stock fell $0.18 per share, or 5.55%, to close at $3.06 on May 12, 2026.

According to the complaint, on August 28, 2026, Anavex filed with the SEC an amended Annual Report on Form 10-K/A for the fiscal year ended September 30, 2025, indicating that "there was a material weakness in internal control over financial reporting that existed on September 30, 2025. Accordingly, the Company's internal control over financial reporting as of September 30, 2025, as reported in its Annual Report on Form 10-K for the fiscal year ended September 30, 2025 (the "Original Form 10-K") was not effective. In addition, the Company's disclosure controls and procedures were not effective as of September 30, 2025, due to the material weakness in internal control over financial reporting as described above." The Company also filed an amended quarterly report on Form 10-Q/A for the fiscal quarter ended December 31, 2025, indicating that, like the 10-K/A, the Company's internal control over financial reporting and disclosure controls and procedures as of December 31, 2025 were not effective.

Plaintiff also alleges that on August 28, 2026, the Company filed with the SEC its quarterly reports for the periods ending March 31, 2026 and June 30, 2026, which contained disclosures regarding the Company's clinical trials and internal controls. On this news, Anavex stock fell $0.19 per share, or 6.35%, to close at $2.80 on August 31, 2026, the subsequent trading day.

What Can Anavex Shareholders Do Now?

Investors who purchased or otherwise acquired Anavex Life Sciences Corp. securities during the Class Period may be eligible to serve as lead plaintiff. The lead plaintiff is a court-appointed investor who represents the interests of all class members throughout the litigation. Stockholders who wish to seek appointment as lead plaintiff must move the court no later than November 30, 2026. Contact Robbins LLP for information about the appointment process.

Shareholders do not need to serve as lead plaintiff to share in any potential recovery. Investors who do not seek appointment may remain absent class members.

Does It Cost Anything to Participate?

No. Robbins LLP represents investors on a contingency fee basis, with no upfront or out-of-pocket fees or expenses.

Why Robbins LLP?

A recognized leader in shareholder rights litigation, Robbins LLP represents investors in securities fraud and shareholder derivative litigation. We have helped restore more than $2 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.

"Companies have an obligation to provide investors with complete and accurate information so that markets can function fairly and efficiently," said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against Anavex Life Sciences Corp. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Contact Robbins LLP

Investors seeking additional information about the Anavex Life Sciences Corp. securities class action may contact Robbins LLP by submitting an inquiry, emailing attorney Aaron Dumas, Jr., or calling (800) 350-6003.

Attorney Advertising. Past results do not guarantee a similar outcome.

SOURCE Robbins LLP

Share this article

Days after a rally, Innodata shares fell nearly 20% before the opening bell on October 27, 2026, following a report of nearly 550 layoffs in India and the Philippines. The investigation concerns whether investors may not have been adequately informed of the risk of a reduction in business that reportedly led to the workforce reduction.

NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Innodata Inc. (NASDAQ: INOD) shares reversed on October 27, 2026, falling more than 20% in premarket trading to open at $48.40 after reports indicated that the Company had laid off nearly 550 employees in India and the Philippines. Innodata has not yet commented on the news. If you bought INOD and are now holding a loss, see whether your INOD losses may be recoverable. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (888) SueWallSt.

The selling hit before regular-session trading opened, but did not stop there. By midmorning, the stock was trading below $45, representing a decline of about 25% from the October 26, 2026 closing price.

According to the report, the termination notice for the 550 employees cited a reduction in business assignments rather than terminating the employees for issues of personal performance. In its most recent 10-K filing, Innodata indicated they "employed 10,107 employees," as of December 31, 2025, suggesting the cut likely represented more than 5% of the Company's global workforce.

SueWallSt notifies investors of a pending investigation into potential securities law violations, including whether Innodata may not have adequately disclosed the risk of a reduction in work for the region and the potential impact on the Company's growth narrative. INOD investors who lost money in the October 27 selloff are encouraged to submit their loss details for review or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the INOD Investigation

Q: How much did INOD stock drop?A: Shares fell more than 19% at market open, a decline of approximately $11.51 per share, to open at $48.40 on October 27, 2026. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.

Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Innodata made materially false or misleading statements regarding its workforce, operating capacity, and growth prospects. The stock price declined sharply on October 27, 2026, when a report surfaced that the Company had laid off nearly 550 employees in India and potentially additional workers in the Philippines due to a cited "reduction in business assignments."

Q: When did Innodata allegedly mislead investors?A: The investigation concerns statements made before the October 27, 2026 report that allegedly caused investors to purchase securities at inflated prices.

Q: What do INOD investors need to do right now?A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my INOD shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought INOD and sold at a loss may still participate in the investigation.

Q: Do I need to go to court or give testimony?A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

Q: What does it cost me to participate?A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (888) SueWallSt

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE SueWallSt.com

Share this article

KLEVV UNVEILS ALL-NEW CRAS V RGB PRIME DDR5 GAMING/OC MEMORY

SUPPORTS AMD EXPO⢠Technology: Featuring Ultra Low Latency

WITH AWARD-WINNING FLAGSHIP DESIGN

HONG KONG, Oct. 27, 2026 /PRNewswire/ -- KLEVV, the leading consumer memory and storage brand introduced by Essencore, unveils the all-new CRAS V RGB PRIME DDR5 Gaming/OC Memory. Purpose-built for elite gaming rigs and demanding creative workloads, this new premium memory unleashes ultra-low CAS latency down to CL26 at 6000 MT/s and blazing overclocking speeds of up to 8000 MT/s at CL38, dressed in a striking black-and-gold finish and armed with dual-platform overclocking support for gamers, PC builders, and performance enthusiasts who demand nothing but the best.

Refined Flagship Design and Craftsmanship

Building on the aluminum heat spreader design of the flagship CRAS V RGB, winner of both the Red Dot and iF Design Awards, the CRAS V RGB PRIME introduces a striking new black-and-gold interpretation of the series' signature look.

An advanced hard-anodizing process, combined with a specialized surface treatment, gives the modules a smooth, piano-lacquer-like sheen that adds depth and sophistication from every angle. The result is an understated yet luxurious aesthetic that offers users a fresh, premium design choice while preserving the refined craftsmanship of the original CRAS V RGB.

High-Speed Performance with Lower Latency

The CRAS V RGB PRIME further advances KLEVV's DDR5 overclocking memory lineup with tested speeds of 6000, 6400, and 8000 MT/s and CAS latencies of CL26, CL28, and CL38, respectively.

The 6000 MT/s configuration features tested timings of 26-36-36-76, while the 6400 MT/s configuration delivers timings of 28-38-38-78. For users seeking extreme frequencies, the 8000 MT/s models operate at tested timings of 38-48-48-128. All configurations are tested at 1.4V.

The 6000 and 6400 MT/s configurations are available in dual-channel kits ranging from 32GB (16GBx2), 64GB (32GBx2), to 128GB (64GBx2), while the 8000 MT/s models are offered in both 32GB (16GBx2) and 48GB (24GBx2) kits. This diverse range gives users greater flexibility to select the ideal balance of speed, latency, and capacity for their systems.

Next-Generation AMD EXPO⢠Technology: Featuring Ultra Low Latency

"AMD EXPO⢠Technology: Featuring Ultra Low Latency" is the latest evolution of AMD's established memory overclocking technology. The new AMD EXPO ULL profile incorporates optimized memory sub-timing settings designed to reduce latency and improve overall performance on compatible AMD platforms. As the first product in KLEVV's overclocking memory lineup to adopt this technology, the CRAS V RGB PRIME delivers a more responsive gaming and overclocking experience.

The 6000 MT/s and 6400 MT/s 32GB (16GBx2) configurations are certified for AMD EXPO Ultra Low Latency. According to AMD, certified Ultra Low Latency memory can deliver an average 4% improvement in FPS compared with non-ULL AMD EXPO memory on compatible systems.*

Broad Intel and AMD Platform Support

Offering broad support across the latest desktop platforms, the CRAS V RGB PRIME is compatible with AMD Ryzen⢠processors on the AM5 platform and Intel® Core⢠Ultra 200S Plus processors.

Each kit comes preloaded with both Intel® Extreme Memory Profile and AMD EXPO⢠Technology overclocking profiles, allowing users to unlock high-speed performance through a simple BIOS setting on compatible motherboards with supported BIOS versions. With both profiles included, users can confidently choose their preferred speed and capacity without the hassle of selecting separate Intel- or AMD-specific models.

Premium Components for Uncompromising Stability

The CRAS V RGB PRIME features rigorously screened, high-quality memory ICs from a leading Korean manufacturer, ensuring consistent high-speed performance and exceptional stability under demanding workloads.

Paired with a high-density 10-layer PCB, the modules deliver enhanced signal integrity and greater resistance to interference during high-speed operation. Integrated PMIC and on-die ECC technologies further support stable power management and long-term reliability, creating a robust foundation for gaming and overclocking performance.

To ensure broad compatibility, the CRAS V RGB PRIME has also been validated on the QVLs (Qualified Vendor Lists) of four major motherboard manufacturers. Its RGB lighting supports ASUS Aura Sync, GIGABYTE RGB Fusion, MSI Mystic Light Sync, and ASRock Polychrome Sync, allowing users to seamlessly coordinate lighting across compatible components and systems.

A Complete DDR5 Gaming/OC Memory Lineup

The introduction of the CRAS V RGB PRIME further expands KLEVV's comprehensive DDR5 Gaming/OC memory portfolio.

With the CRAS, URBANE, BOLT, and FIT series available across a wide range of designs and specifications, KLEVV continues to provide flexible memory choices for different performance requirements, system configurations, and aesthetic preferences.

Warranty and Availability

The CRAS V RGB PRIME DDR5 comes with a limited lifetime peace of mind warranty and will be available from November 2026. Please visit the KLEVV website to check product availability across online and offline retail channels. 

ABOUT KLEVV

KLEVV is a premium brand of Essencore, a major vendor of memory modules and NAND flash application products. The KLEVV range focuses on high-performance gaming memory modules and solid-state drives, engineered for enthusiasts who demand world-class quality and reliability. KLEVV memory and SSD products have been recognized with Germany's Red Dot Design Award and iF Design Award for their innovative design. For more information, please visit www.klevv.com.

ABOUT ESSENCORE

Established in 2014, Essencore Limited aims to become the world's top vendor of DRAM modules and NAND flash application products. The company started with one goal: to "Change the world and be a leader in semiconductor distribution." The business strategies of Essencore are to adopt the newest technologies to differentiate themselves from competitors, deliver dedicated Memory products, and offer various product portfolios for customers' competition readiness. For more information, please visit www.essencore.com.

*Based on AMD testing. Actual performance may vary depending on processor, motherboard, BIOS version, memory configuration, and application workload.

Overclocking and/or Undervolting AMD processors and memory, including without limitation, altering clock frequencies / multipliers or memory timing / voltage, to operate outside of AMD's published specifications will void any applicable AMD product warranty, even when enabled via AMD hardware and/or software. This may also void warranties offered by the system manufacturer or retailer. Users assume all risks and liabilities that may arise out of overclocking / undervolting AMD processors, including, without limitation, failure of or damage to hardware, reduced system performance and/or data loss, corruption or vulnerability. GD-106.

SOURCE Klevv

Share this article

Bringing avatars, outfits, and other creations by Japanese creators to users around the world

TOKYO, Oct. 27, 2026 /PRNewswire/ -- transcosmos today announced a partnership with Metaverse Creators Inc. (Headquarters: Tokyo, Japan; CEO: Kazuo Wakamiya) to begin the global distribution of VRChat 3D content planned, produced, and sold by Metaverse Creators through Geek Jack, transcosmos's cross-border e-commerce platform specializing in entertainment products. Through this partnership, avatar, outfit, hairstyle, accessory, and other 3D content will be gradually introduced on Geek Jack. transcosmos and Metaverse Creators will strengthen their sales and marketing framework to bring the works of Japanese creators to a broader global audience.

- Background

In VR social platforms such as VRChat, a culture has emerged in which users connect across countries and regions while enjoying 3D content such as avatars, outfits, and accessories. While high-quality 3D content created by Japanese creators continues to attract growing interest from overseas audiences, challenges related to language, payment processing, marketing, and sales operations can create barriers for individual creators seeking to expand internationally.

Metaverse Creators has been working with leading creators in the metaverse space to plan, produce, and sell VRChat avatars, outfits, and other virtual items, while helping create an environment in which creators can continue to thrive.

Geek Jack is a cross-border e-commerce platform specializing in the entertainment category and operated by transcosmos. Since launching digital downloads of Japan-originated VTuber voice content in July 2019, Geek Jack has expanded its offerings to include both digital and physical products for customers around the world. Since 2023, Geek Jack has also offered VRChat avatars, outfits, and other products, strengthening its lineup of 3D model content for VR social platforms and the metaverse.

This partnership was established to further expand opportunities for Japanese 3D content to reach global audiences by combining Metaverse Creators's expertise in planning and producing 3D content and its creator network with Geek Jack's cross-border e-commerce infrastructure.

- About the partnership

Under this partnership, transcosmos and Metaverse Creators will focus on the following initiatives:

- Overseas sales of VRChat 3D content

Avatars, outfits, hairstyles, accessories, and other VRChat 3D content planned, produced, and sold by Metaverse Creators will be gradually made available on Geek Jack. The partnership will establish a streamlined shopping journey that enables overseas users to easily discover and purchase these creations.

- Strengthening outreach to overseas users

To bring product information and the unique appeal of creators to overseas users, promotional activities and product communications for international audiences will be strengthened. Beyond simply selling products, the partnership will communicate the creative vision and story behind each work, creating new opportunities for engagement between creators and fans around the world.

- Supporting creators' sustainable global expansion

In addition to Metaverse Creators's expertise in creator support, the partnership will leverage Geek Jack's multilingual customer support capabilities and the proven track record of "Modesapo!" in addressing unauthorized distribution and reposting of creators' works. By reducing the operational burden associated with international sales, the partnership will help creators focus on content creation while building an environment that enables them to continuously reach audiences around the world.

- Next steps

Through this partnership, transcosmos and Metaverse Creators will continue to expand the range of 3D content and participating creators on Geek Jack, bringing Japan-originated avatar culture and 3D creative works to users around the world. The partnership will also leverage feedback and demand from overseas users to inform future product development and promotional activities, with the goal of building a sustainable distribution ecosystem that creates new revenue opportunities and fan engagement for creators.

- About Geek Jack

Geek Jack is a cross-border e-commerce platform operated by transcosmos and focused on entertainment products. Since July 2019, it has offered digital downloads of Japan-originated VTuber voice content. Today, in addition to digital products, Geek Jack sells physical merchandise to customers across countries and regions worldwide. Geek Jack is also expanding its lineup of 3D model content for VR social platforms and the metaverse, as well as music-related products. Official website: https://shop.geekjack.net/

- About Metaverse Creators Inc. (https://metaverse-creators.tokyo/)

Metaverse Creators supports the growth of creators while working alongside them from planning through development, helping bring content created by Japanese creators to global audiences. Across a wide range of metaverse platforms, including VRChat and Roblox, Metaverse Creators provides end-to-end support covering everything from content creation to promotion. The company remains committed to establishing Japan-originated metaverse culture as a global cultural standard.

*transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.

*Other company names and product or service names used here are trademarks or registered trademarks of respective companies.

- About transcosmos inc.

transcosmos launched its operations in 1966. Since then, we have united superior "people" with cutting-edge "technology" to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients' business processes, focusing on both sales expansion and cost optimization through our 189 bases across 36 countries/regions with a focus on Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of the e-commerce market on a global scale, transcosmos provides comprehensive One-Stop Global E-Commerce Services to deliver our clients' excellent products and services to consumers in 46 countries/regions around the globe. transcosmos is committed to treating the challenges of its clients and society as its ownâdiscussing and addressing their issues from planning to executionâand Make It Real, Together. Visit us here https://www.trans-cosmos.co.jp/english/

SOURCE transcosmos inc.

Share this article

TOTAL PLAY ANNOUNCES REVENUE OF Ps.11,496 MILLION AND EBITDA OF Ps.4,944 MILLION FOR THE THIRD QUARTER OF 2026

âGrowth of 143,340 net subscribers for Totalplay Residential demonstrates a strong preference for the company's world-class internet servicesâ

âThe balance of EBITDA less Capex and interest reaches Ps. 2,131 million in the first nine months of 2026â

â5% reduction in the net debt balance provides additional strength to the company's capital structureâ

MEXICO CITY, Oct. 27, 2026 /PRNewswire/ -- Total Play Telecomunicaciones, S.A.P.I. de C.V. ("Total Play"), a leading telecommunications company in Mexico, which offers internet access, pay television and telephony services, through one of the largest 100% fiber optic networks in the country, announced today financial results for the third quarter of 2026.

"The strong preference among an increasing number of users for our technologically advanced internet services â which offer superior speed and stability â drove a solid net increase of 143,340 Totalplay Residential subscribers during the quarter," commented Eduardo Kuri, CEO of Total Play. "This growth was supported by more intensive use of the company's fiber-optic network, as we added more subscribers to our world-class infrastructure without requiring additional investment in geographic coverage."

"Regarding the balance sheet, we were able to reduce the company's net debt balance by 5% as a result of various debt of loans with cost amortizations during the period. These included Ps.500 million in Cebures issued in 2024 â paid this quarter â, US$46 million in Senior Secured Notes due 2028 â done during the first nine months of the yearâ and US$56 million of the remaining Senior Notes due 2025, which were amortized in November of the previous year. Additionally, we reduced lease liabilities by Ps.776 million, which further strengthened Total Play's capital structure," added Mr. Kuri.

Third quarter results

Quarterly revenue was Ps.11,496 million, compared to Ps.11,301 million in the same period of the previous year. Total costs and expenses were Ps.6,552 million, up from Ps.6,202 million the year before.

As a result, Total Play's EBITDA was Ps.4,944 million, compared to Ps.5,099 million a year ago; the EBITDA margin for the quarter was 43%. The company recorded an operating profit of Ps.691 million, up from Ps.390 million the previous year.

Totalplay reported a net loss of Ps.1,331 million, compared to a loss of Ps.665 million in the same quarter of 2025.

Amounts in millions of pesos.

EBITDA: Earnings before interest, taxes, depreciation, and amortization.

Revenue from services

The company's revenue increased by 2%, as a result of 3% growth in sales of the residential segment and 10% reduction in revenue from the enterprise business.

The increase in revenue for Totalplay Residencial â to Ps.10,169 million from Ps.9,827 million the previous year â is related to 8% growth in the number of the company's service subscribers compared to the same quarter of the prior year, reaching 5,819,286 this period (a figure that includes 68,793 small and medium-sized enterprises). Compared to the previous quarter, the subscriber base grew by 143,340 users. The company believes that the number of users reached this quarter reflects its notable capacity to offer technologically advanced internet services â characterized by superior stability and speed â as well as continuous innovation in its entertainment platform and excellence in service.

Average revenue per user (ARPU) for the quarter was Ps.576, from Ps.598 a year ago. This decline in ARPU is largely attributable to an increasing proportion of users with double-play packages â compared to those with triple-play packages â within the total base of residential subscribers.

The number of homes passed by Total Play in Mexico at the end of this period was 19.5 million, up from 17.6 million a year earlier.

Penetration â the proportion of homes passed by Total Play that subscribe to the company's telecommunications services â was 29.8% at the end of the quarter, compared to 30.6% a year earlier.

Revenue for the enterprise segment was Ps.1,327 million, compared to Ps.1,474 million the previous year. The decrease is due to projects with a predetermined duration that concluded this period.

Costs and expenses

Total costs and expenses increased 6%, as a result of 12% growth in service costs and 3% increase in general expenses.

The increase in costs â to Ps.1,784 million, up from Ps.1,591 million the previous year â is primarily due to higher membership costs, partially offset by lower costs related to enterprise projects, as well as lower link rents.

The increase in expenses, to Ps.4,768 million, from Ps.4,611 million, reflects higher personnel, advertising and promotion expenses this period.

EBITDA and net result

Total Play's EBITDA was Ps.4,944 million, compared to Ps.5,099 million the previous year.

Relevant variations below EBITDA were the following:

A reduction of Ps. 456 million in depreciation and amortization, resulting from the end of the useful life of a group of assets.

A decrease of Ps. 264 million in accrued interest expense, in the context of a reduction in the company's debt with cost balance during the period.

A foreign exchange loss of Ps.453 million â compared to a foreign exchange gain of Ps.828 million a year earlier â resulting from a net monetary liability position in foreign currency, combined with depreciation of the peso against the basket of currencies in which the company's monetary liabilities are denominated during this quarter, compared to appreciation in the prior year.

Total Play reported a net loss of Ps.1,331 million, compared to a loss of Ps.665 million in the same period of 2025.

Balance sheet

As of September 30, 2026, the company's debt with cost was Ps. 55,157 million, 4% lower than Ps. 57,338 million recorded a year earlier. This reduction is the result of various debt of loans with cost amortizations during the period, including Ps. 500 million in Cebures issued in 2024 â paid this quarter â US$46 million in Senior Secured Notes due 2028 â done during the first nine months of the year â and US$56 million representing the remainder of Senior Notes due 2025, which were amortized in the fourth quarter of the previous year.

The lease liability was Ps.2,480 million, 24% lower compared to Ps.3,256 million the previous year.

The balance of cash and cash equivalents, as well as restricted cash held in trusts, was Ps.6,780 million, compared to Ps.6,981 million a year earlier. As a result, the company's net debt was Ps.50,857 million, 5% lower than the Ps.53,613 million recorded the previous year.

The leverage ratio â Net Debt / EBITDA for the last two quarters, annualized â was 2.54x.

Total Play's fixed assets â which include cumulative investment in fiber optics, telecommunications equipment, and subscriber acquisition costs, among other assets â was Ps.76,921 million, compared to Ps.82,239 million a year ago.

Nine-month results

Revenue for the first nine months of 2026 was Ps.34,033 million â 1% higher than the Ps.33,695 million recorded in the previous year â reflecting a 2% increase in residential revenue and an 8% decrease in enterprise revenue. Total costs and expenses rose 6% to Ps.19,166 million, up from Ps.18,115 million, driven by 6% increase in general expenses and 6% growth in service costs.

Total Play reported EBITDA of Ps.14,867 million, compared to Ps.15,580 million the previous year; the EBITDA margin for the period was 44%. Operating profit was Ps. 1,645 million, compared to Ps. 1,647 million in the same period of 2025.

The company recorded net loss of Ps.3,020 million, compared to a loss of Ps.2,446 million a year ago.

Amounts in millions of pesos.

EBITDA: Earnings before interest, taxes, depreciation, and amortization.

About Total Play

Total Play is a leading Triple Play provider in Mexico that, thanks to the widest direct-to-home fiber optic network in the country, offers entertainment and technologically advanced services with the highest quality and speed in the market. For the latest news and updates about Total Play, visit: www.totalplay.com.mx.

Total Play is a Grupo Salinas company (www.gruposalinas.com), a group of dynamic, fast-growing, and technologically advanced companies focused on creating economic value through market innovation and goods and services that improve standards of living; social value to improve community well-being; and environmental value by reducing the negative impact of its business activities. Created by Mexican entrepreneur Ricardo B. Salinas (www.ricardosalinas.com), Grupo Salinas operates as a management development and decision forum for the top leaders of member companies. Each of the Grupo Salinas companies operates independently, with its own management, board of directors, and shareholders. Grupo Salinas has no equity holdings. The group of companies shares a common vision, values, and strategies for achieving rapid growth, superior results, and world-class performance.

Except for historical information, the matters discussed in this press release are concepts about the future that involve risks and uncertainty that may cause actual results to differ materially from those projected. Other risks that may affect Total Play and its subsidiaries are presented in documents sent to the securities authorities.

SOURCE Total Play Telecomunicaciones, S.A.P.I. de C.V.

Share this article